Antimicrobial resistance (AMR) has emerged as a critical global health challenge, driven largely by the inappropriate use of antimicrobial agents. Antimicrobial Stewardship Programs (ASPs) are essential strategies designed to optimize antimicrobial use, improve patient outcomes, and reduce resistance. This study explores the pivotal role of clinical pharmacists within ASPs in combating AMR. Clinical pharmacists contribute significantly through interventions such as formulary management, dose optimization based on pharmacokinetic and pharmacodynamic principles, de-escalation of therapy, and therapeutic drug monitoring. Additionally, their involvement in surveillance, audit, feedback, and interprofessional collaboration enhances the effectiveness of stewardship initiatives. Evidence suggests that pharmacist-led interventions improve prescribing practices, reduce unnecessary antimicrobial use, and lower healthcare costs. Despite these benefits, challenges such as limited resources, lack of awareness, and insufficient integration of pharmacists into healthcare teams persist. Strengthening the role of clinical pharmacists through structured training, policy support, and multidisciplinary collaboration is crucial for the successful implementation of ASPs. Ultimately, empowering clinical pharmacists can significantly contribute to controlling AMR and improving global health outcomes.
Saba Hameed Majeed (Thu,) studied this question.